Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
Journal of the Society for Gynecologic Investigation
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Rodriguez, G. C.
Right arrow Articles by Hughes, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez, G. C.
Right arrow Articles by Walmer, D. K.
Right arrow Articles by Cline, M.
Right arrow Articles by Krigman, H.
Right arrow Articles by Lessey, B. A.
Right arrow Articles by Whitaker, R. S.
Right arrow Articles by Dodge, R.
Right arrow Articles by Hughes, C. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ETHINYLESTRADIOL
*LEVONORGESTREL
Medline Plus Health Information
*Ovarian Cancer
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Effect of Progestin on the Ovarian Epithelium of Macaques: Cancer Prevention Through Apoptosis?

Gustavo C. Rodriguez, MD

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham; Division of Reproductive Endocrinology. Department of Obstetrics and Gynecology, Duke University Medical Center, Durham and Laboratory of Reproductive and Development Toxicology. National Institute for Environmental Health Science, National Institutes of Health, Research Triangle Park: Department of Comparative Medicine, Bowman Gray School of Medicine, Winston-Salem: Department of Pathology, Duke University Medical Center, Durham: Division of Reproductive Endocrinology, University of North Carolina Medical Center, Chapel Hill; Department of Bistatistics, Duke Comprehensive Cancer Center. Duke University Medical Center, Durham; Division of Reproductive Biology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Caroliona; DUMC 3079, Division of Gynecologic Oncology, Department of OB/GYN, Duke University Medical Center, Durham, NC 27710

David K. Walmer, MD, PhD

Mark Cline, DVM, PhD

Hannah Krigman, MD

Bruce A. Lessey, MD, PhD

Regina S. Whitaker, BS

Richard Dodge, MS

Claude L. Hughes, MD, PhD

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham; Division of Reproductive Endocrinology. Department of Obstetrics and Gynecology, Duke University Medical Center, Durham and Laboratory of Reproductive and Development Toxicology. National Institute for Environmental Health Science, National Institutes of Health, Research Triangle Park: Department of Comparative Medicine, Bowman Gray School of Medicine, Winston-Salem: Department of Pathology, Duke University Medical Center, Durham: Division of Reproductive Endocrinology, University of North Carolina Medical Center, Chapel Hill; Department of Bistatistics, Duke Comprehensive Cancer Center. Duke University Medical Center, Durham; Division of Reproductive Biology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Caroliona

Objective: The apoptosis pathway is a vital mechanism in vivo that functions to eradicate genetically damaged cells prone to malignancy. The purpose of this study was to determine whether oral contraceptives, which confer significant protection against subsequent epithelial ovarian cancer, induce apoptosis in the ovarian epithelium.

Methods: Female cynomologus macaques (N = 75) were randomized to receive a diet for 35 months containing either no hormones, the oral contraceptive Triphasil (Wyeth-Ayerst Laboratories, Philadelphia, PA), the estrogenic component of Triphasil (ethinyl estradiol) alone, or the progestin component of Triphasil (levonorgestrel) alone, each administered in a cyclic fashion. At study termination, the animals underwent ovariectomy and the ovarian epithelium was examined morphologically and immunihistochemically for apoptosis. The percentage of ovarian epithelial cells undergoing apoptosis was measured in each animal and compared between the treatment groups.

Results: The median percentage of ovarian epithelial cells undergoing apoptosis by treatment was control (3.8%), ethinyl estradiol (1.8%), Triphasil (14.5%), and levonorgesrel (24.9%). Compared with control and ethinyl estradiol-treated monkeys, a statistically significant increase in the proportion of apoptotic cells was noted in the ovarian epithelium of monkeys treated with the oral contraceptive Triphasil (P ≤ .01) or levonorgestrel (P < .001), with a maximal effect (six-fold) seen in the group treated with levonorgestrel alone.

Conclusion: Oral contraceptive progestin induces apoptosis in the ovarian epithelium. Given the importance of the apoptosis pathway for cancer prevention, an effective chemopreventive strategy may be possible using progestins or other agents that selectively induced apoptosis in the ovarian epithelium to prevent the development of ovarian cancer.

Key Words: Progetins • apoptosis • ovarian cancer • oral contraceptives

Journal of the Society for Gynecologic Investigation, Vol. 5, No. 5, 271-276 (1998)
DOI: 10.1177/107155769800500508


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?